Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes - Related Studies

Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes (SNOW)

This study is currently recruiting participants.

Verified April 2012 by Montreal Heart Institute

Study NCT01586442 Information provided by Montreal Heart Institute

First Received on April 24, 2012. Last Updated on April 25, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Eplerenone
Spironolactone

Additional drug interventions recognized in this trial

Mineralocorticoids

More general drug interventions related to this trial

Sponsors listed in this trial

Montreal Heart Institute
Pfizer